Semaglutide, the weight management drug sold as Ozempic and Wegovy, may reduce the risk of Alzheimer's disease by 40% to 70% ...

Diagnosis of Alzheimer's disease (AD) is currently largely based on the presence of biomarkers. This may lead to a ...

U.S. drugmaker AbbVie said on Monday it will buy Aliada Therapeutics for $1.4 billion in cash, betting on an experimental ...

There is a lot of outrage that the new Alzheimer’s drug donanemab is being refused on the NHS. But there are good reasons for ...

The team compared a hypothetical disease-modifying treatment with the best supportive care ... mild cognitive impairment (MCI) due to Alzheimer’s disease, mild Alzheimer’s disease, moderate ...

Treatment for Alzheimer’s hallucinations may include ... is experiencing hallucinations due to Alzheimer’s disease, the best thing you can do is stay calm and focus on keeping your loved ...

Presymptomatic individuals who are at a high risk of developing AD “should be the target for clinical trials in the future” ...

Chris Hemsworth shares a heartfelt health update prioritizing family and wellness after discovering his increased risk for ...

The Alzheimer's Association says more than 122,000 Missourians 65 years and older are battling Alzheimer's Disease, which has ...

Sinaptica Therapeutics, Inc., a clinical-stage company leading the development of a new class of personalized neuromodulation therapeutics to treat Al ...

The Prix Galien USA Best Startup category recognizes outstanding innovation by therapeutics-focused life science companies that have not yet ...